Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias.

× No keyword cloud information.

31 in total

1. [Studies in the benzofuran series. VII. Preliminary pharmacological study of 2-butyl-3-(3,5-diiodo-4-beta-N-diethylaminoethoxybenzoyl)-benzofuran].

Authors: R CHARLIER; G DELTOUR; R TONDEUR; F BINON
Journal: Arch Int Pharmacodyn Ther Date: 1962-09-01

2. The ocular complications of chloroquine therapy.

Authors: H E HOBBS; C D CALNAN
Journal: Lancet Date: 1958-06-07 Impact factor: 79.321

3. Letter: Amiodarone and neurological side-effects.

Authors: F Lustman; G Monseu
Journal: Lancet Date: 1974-03-30 Impact factor: 79.321

4. Cardiac electrophysiology.

Authors: D M Krikler
Journal: Lancet Date: 1974-05-04 Impact factor: 79.321

5. Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone.

Authors: M H Jonckheer; P Blockx; R Kaivers; G Wyffels
Journal: Acta Cardiol Date: 1973 Impact factor: 1.718

6. [Research on the benzofuran series. XXXVII. Comparative study of transit and metabolism of amiodarone in different species of animals and humans].

Authors: J Broekhuysen; R Laruel; R Sion
Journal: Arch Int Pharmacodyn Ther Date: 1969-02

7. Atrial fibrillation complicating Wolff-Parkinson-White syndrome treated with amiodarone.

Authors: D A Chamberlain; A N Clark
Journal: Br Med J Date: 1977-12-10

8. [Clinical study of amiodarone in cardiac rhythmic disorders].

Authors: J Van Schepdael; H Solvay
Journal: Presse Med Date: 1970-10-10 Impact factor: 1.228

9. Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.

Authors: B N Singh; D E Jewitt; J M Downey; E S Kirk; E H Sonnenblick
Journal: Clin Exp Pharmacol Physiol Date: 1976 Sep-Oct Impact factor: 2.557

10. Clinical efficacy of amiodarone as an antiarrhythmic agent.

Authors: M B Rosenbaum; P A Chiale; M S Halpern; G J Nau; J Przybylski; R J Levi; J O Lázzari; M V Elizari
Journal: Am J Cardiol Date: 1976-12 Impact factor: 2.778

9 in total

1. Amiodarone increases plasma digoxin concentrations.

Authors: J O Moysey; N S Jaggarao; E N Grundy; D A Chamberlain
Journal: Br Med J (Clin Res Ed) Date: 1981-01-24

2. [Iatrogenic histopathological findings. A systematic compilation].

Authors: R Vock
Journal: Z Rechtsmed Date: 1984

3. Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.

Authors: M Stäubli; J Bircher; R L Galeazzi; H Remund; H Studer
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

4. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.

Authors: W J McKenna; C M Oakley; D M Krikler; J F Goodwin
Journal: Br Heart J Date: 1985-04

5. Amiodarone-induced thyrotoxicosis: four cases and a review of the literature.

Authors: S Keidar; E Grenadier; A Palant
Journal: Postgrad Med J Date: 1980-05 Impact factor: 2.401

Review 6. New antiarrhythmic drugs.

Authors: P F Nestico; J Morganroth; L N Horowitz
Journal: Drugs Date: 1988-03 Impact factor: 9.546

Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias.